Innospec Quarterly Income Statement
NASDAQ: IOSPIndustrialsMajor ChemicalsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Innospec revenue and earnings
In the quarter ended Jun 30, 2026, Innospec generated $491.4 million in revenue, up 11.8% from the same quarter a year earlier. Net income was $30.8 million (+31.1% year over year), for a net margin of 6.3% versus a median of 6.7% in the prior 5 quarters. Gross margin was 28.1% (up from 28.0%) and operating margin 8.1%.
Diluted earnings per share came in at $1.25, up from $0.94.
Summary generated from market data by MetaCap's automated system. Methodology
Innospec income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 491.40M | 453.20M | 455.60M | 441.90M | 439.70M | 440.80M | 466.80M | 443.40M | 435.00M | 500.20M | 494.70M | 464.10M |
| Revenue growth (YoY) | +11.76% | +2.81% | -2.40% | -0.34% | +1.08% | -11.88% | -5.64% | -4.46% | -9.45% | -1.84% | -3.13% | -9.53% |
| Cost of Revenue | 353.10M | 329.70M | 328.20M | 325.20M | 316.50M | 315.70M | 330.60M | 319.30M | 308.10M | 344.50M | 339.00M | 326.90M |
| Gross Profit | 138.30M | 123.50M | 127.40M | 116.70M | 123.20M | 125.10M | 136.20M | 124.10M | 126.90M | 155.70M | 155.70M | 137.20M |
| Operating Expenses | 98.60M | 87.00M | 80.60M | 110.80M | 88.90M | 82.60M | 95.10M | 78.50M | 86.20M | 105.20M | 111.20M | 95.30M |
| Research & Development | 14.20M | 13.20M | 11.00M | 13.70M | 13.60M | 12.70M | 14.90M | 13.60M | 14.00M | 14.00M | 16.20M | 11.60M |
| Selling, General & Admin | 84.30M | 78.50M | 69.30M | 71.90M | 74.60M | 69.30M | 78.90M | 64.30M | 71.60M | 90.50M | 95.00M | 83.70M |
| Operating Income | 39.70M | 36.50M | 46.80M | 5.90M | 34.30M | 42.50M | 41.10M | 45.60M | 40.70M | 50.50M | 44.50M | 41.90M |
| Other Income (Expense) | 1.10M | 2.60M | 1.60M | 3.40M | -4.70M | 300.00K | 9.50M | -3.50M | 900.00K | 2.70M | -700.00K | 4.80M |
| Pretax Income | 41.60M | 39.90M | 50.30M | 11.50M | 32.30M | 45.20M | -102.60M | 44.80M | 43.70M | 55.30M | 45.30M | 47.50M |
| Income Tax | 10.40M | 9.10M | 2.90M | -1.40M | 8.40M | 11.60M | -32.20M | 11.40M | 12.50M | 13.90M | 7.50M | 8.30M |
| Net Income | 30.80M | 30.40M | 47.40M | 12.90M | 23.50M | 32.80M | -70.40M | 33.40M | 31.20M | 41.40M | 37.80M | 39.20M |
| Net Income growth (YoY) | +31.06% | -7.32% | — | -61.38% | -24.68% | -20.77% | -286.24% | -14.80% | +7.96% | +24.70% | +48.24% | +1.29% |
| EPS (Basic) | 1.25 | 1.23 | 1.92 | 0.52 | 0.94 | 1.31 | -2.82 | 1.34 | 1.25 | 1.66 | 1.52 | 1.58 |
| EPS (Diluted) | 1.25 | 1.22 | 1.90 | 0.52 | 0.94 | 1.31 | -2.80 | 1.33 | 1.24 | 1.65 | 1.50 | 1.57 |
| Shares Outstanding (Basic) | 24.64M | 24.78M | — | 24.83M | 24.94M | 24.97M | — | 24.94M | 24.94M | 24.89M | — | 24.87M |
| Shares Outstanding (Diluted) | 24.71M | 24.84M | — | 24.91M | 25.04M | 25.10M | — | 25.10M | 25.10M | 25.07M | — | 25.01M |
| EBITDA | 49.70M | 46.40M | 56.20M | 18.10M | 45.40M | 53.40M | 52.00M | 56.70M | 51.80M | 60.90M | 54.70M | 51.80M |
| Gross Margin | 28.14% | 27.25% | 27.96% | 26.41% | 28.02% | 28.38% | 29.18% | 27.99% | 29.17% | 31.13% | 31.47% | 29.56% |
| Operating Margin | 8.08% | 8.05% | 10.27% | 134.00% | 7.80% | 9.64% | 8.80% | 10.28% | 9.36% | 10.10% | 9.00% | 9.03% |
| Net Margin | 6.27% | 6.71% | 10.40% | 2.92% | 5.34% | 7.44% | -15.08% | 7.53% | 7.17% | 8.28% | 7.64% | 8.45% |
This table shows 12 quarterly periods of Innospec's income statement, from Q2 2026 back to Q3 2023, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow IOSP's reporting calendar. What is a income statement?